Senior-led
Clients work directly with experienced advisors throughout the engagement.
Henley provides independent services to biotech companies and the investors who fund them on clinical trial outsourcing, CRO selection and investment decisions.
We work with biotech companies and the investors who fund them on important clinical outsourcing and investment decisions.
Independent advice on clinical trial outsourcing, CRO selection, RFPs and proposal review, budgets and contracts, and CRO oversight and governance.
Explore Biotech Services →Independent commercial and operational advice for investors in clinical-stage biotech, covering investment due diligence, clinical programme assessment and portfolio support.
Explore Investor Advisory →Henley was created to provide straightforward, independent advice based on first-hand industry experience.
Clients work directly with experienced advisors throughout the engagement.
Our advice is based on what we believe is right for the client and the decisions they need to make.
We work in areas where we have direct experience and bring in specialist expertise when an engagement requires it.
Client work is private. Relevant experience and references can be discussed directly.
Our experience spans commercial leadership, clinical trial outsourcing and executive governance across a broad range of clinical development programmes, therapeutic areas and outsourcing models.

If you are considering a clinical outsourcing decision, CRO growth strategy or investment in the sector, we would be happy to talk.